Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma

BACKGROUND: There has been a significant improvement in survival of advanced malignancies with the advent of checkpoint inhibitors. These newer treatment modalities come with a wide spectrum of unique side effects, termed immune related adverse events (irAE), ranging from mild skin rash to severe co...

Descripción completa

Detalles Bibliográficos
Autores principales: Changizzadeh, Pouyan N., Mukkamalla, Shiva Kumar R., Armenio, Vincent A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735540/
https://www.ncbi.nlm.nih.gov/pubmed/29254501
http://dx.doi.org/10.1186/s40425-017-0303-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735540/
https://www.ncbi.nlm.nih.gov/pubmed/29254501
http://dx.doi.org/10.1186/s40425-017-0303-9

Ejemplares similares